Mesenchymal Stem Cells as Therapeutics Agents: Quality and Environmental Regulatory Aspects
Mesenchymal stem cells (MSCs) are one of the main stem cells that have been used for advanced therapies and regenerative medicine. To carry out the translational clinical application of MSCs, their manufacturing and administration in human must be controlled; therefore they should be considered as m...
Saved in:
Main Authors: | Patricia Galvez-Martin, Roger Sabata, Josep Verges, José L. Zugaza, Adolfina Ruiz, Beatriz Clares |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/9783408 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis
by: Aleksandar Arsenijevic, et al.
Published: (2017-01-01) -
Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
by: Zhiping Wei, et al.
Published: (2021-01-01) -
Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine
by: Devang M. Patel, et al.
Published: (2013-01-01) -
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
by: Hongyan Tao, et al.
Published: (2016-01-01) -
Concise Review: The Regulatory Mechanism of Lysine Acetylation in Mesenchymal Stem Cell Differentiation
by: Hong Yang, et al.
Published: (2020-01-01)